Monday’s top analyst upgrades and downgrades included Affirm, BlackRock, Deere, Dick's Sporting Goods, Dollar Tree, Intercontinental Exchange, Mastercard, Merck, Nordstrom, Petrobras and Pure...
Thursday afternoon's analyst upgrades and downgrades included Bandwidth, Live Nation, Krispy Kreme, Twilio, Zendesk and more.
Wednesday's top analyst upgrades and downgrades included American Airlines, Bed Bath & Beyond, Chipotle Mexican Grill, Domino's Pizza, Freeport-McMoRan, Hyatt Hotels, Square and United States Steel.
Tuesday’s top analyst upgrades and downgrades included Affirm, CrowdStrike, CSX, Evergy, FedEx, Knight-Swift, Ryder, Raven Industries, Twilio, Zoom and more.
Tuesday's top analyst upgrades and downgrades included Best Buy, CarMax, Elanco Animal Health, General Motors, Home Depot, Intercontinental Exchange, JD.com, McDonald's, Procter & Gamble and Vonage.
Friday's top analyst upgrades and downgrades included Alteryx, Booking, CarGurus, Datadog, FedEx, First Solar, Uber Technologies, Vonage, Yeti and Zillow.
Tuesday's top analyst upgrades and downgrades included Avaya, Biogen, Broadcom, Chevron, Domino's Pizza, eBay, MGIC Investment, RealReal, Sprout Social, T-Mobile, Zoom Video Communications and Zynga.
Friday's top analyst upgrades and downgrades included Bill.com, CenterPoint Energy, CommScope, Herbalife, Hyatt Hotels, Motorola Solutions, Murphy Oil, Trade Desk and Vonage.
Wednesday's top analyst calls included Apple, CenturyLink, Charles Schwab, Coca-Cola, Dow, Facebook, Gilead Sciences, Intel, Medtronic, Square, TJX and Under Armour.
Solid Biosciences shares jumped on Wednesday after the firm provided an update from its midstage study in Duchenne muscular dystrophy.
Thursday's top analyst upgrades, downgrades and initiations included Citigroup, CommScope, CVS Health, CyberArk, Emerson Electric, Match, Mylan, Qualcomm, Roku, Square, Twitter and Vonage.
Sangamo Therapeutics made a handy gain to start out the week after the firm, in conjunction with Pfizer, announced updated results from a mid-stage trial evaluating a treatment for hemophilia.
The top analyst upgrades, downgrades and initiations seen on Friday included Alkermes, Apple, Canada Goose, FireEye, J.Jill, Kraft Heinz, Uber Technologies and Vonage.
Solid Biosciences shares were crumbling on Tuesday after the firm announced its first-quarter results and an update to its midstage Duchenne muscular dystrophy trial.